Literature DB >> 9401711

Latent inhibition as a measure of learned inattention: some problems and solutions.

R E Lubow1.   

Abstract

The latent inhibition (LI) paradigm has been used to assess attentional dysfunction in various pathological groups. The rationale is based on the assumption that passive stimulus exposure results in the acquisition of an inattentional response to that stimulus. Consequently, compared to a novel stimulus in the same new learning situation, the preexposed stimulus is at a disadvantage. It is argued that methodological and conceptual problems in constructing procedures and designs have created obstacles in relating disrupted LI to psychopathology. Specifically, issues associated with within- and between-subject designs, dichotomous dependent variables, ceiling effects, converging operations, and possible mis-attribution of the LI effect are addressed. Designs and data from several new human-LI paradigms, with normal, de novo Parkinson, and schizophrenic subjects are examined. Results from a multi-condition, within-subject visual search procedure suggest that LI, heretofore attributed only to a deficit in the stimulus preexposed group, may, in part, be due to enhanced performance in the nonpreexposed group. Implications for the design and interpretation of LI experiments, particularly with pathologic groups are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9401711     DOI: 10.1016/s0166-4328(97)02307-3

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

1.  Learning performance of normal and mutant Drosophila after repeated conditioning trials with discrete stimuli.

Authors:  C D Beck; B Schroeder; R L Davis
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

2.  Effects of preexposure and retention interval placement on latent inhibition and perceptual learning in a choice-maze discrimination task.

Authors:  L G De La Casa; William Timberlake
Journal:  Learn Behav       Date:  2006-05       Impact factor: 1.986

3.  Dissociable roles for the nucleus accumbens core and shell in regulating set shifting.

Authors:  Stan B Floresco; Sarvin Ghods-Sharifi; Claudia Vexelman; Orsolya Magyar
Journal:  J Neurosci       Date:  2006-03-01       Impact factor: 6.167

4.  Deficient proactive interference of eyeblink conditioning in Wistar-Kyoto rats.

Authors:  Thomas M Ricart; Matthew A De Niear; Xilu Jiao; Kevin C H Pang; Kevin D Beck; Richard J Servatius
Journal:  Behav Brain Res       Date:  2010-07-17       Impact factor: 3.332

Review 5.  Early life manipulations alter learning and memory in rats.

Authors:  Therese A Kosten; Jeansok J Kim; Hongjoo J Lee
Journal:  Neurosci Biobehav Rev       Date:  2012-07-20       Impact factor: 8.989

6.  Individual learning phenotypes drive collective behavior.

Authors:  Chelsea N Cook; Natalie J Lemanski; Thiago Mosqueiro; Cahit Ozturk; Jürgen Gadau; Noa Pinter-Wollman; Brian H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

7.  The visual search analogue of latent inhibition: implications for theories of irrelevant stimulus processing in normal and schizophrenic groups.

Authors:  R E Lubow; Oren Kaplan
Journal:  Psychon Bull Rev       Date:  2005-04

8.  Nicotinic-serotonergic drug interactions and attentional performance in rats.

Authors:  Amir H Rezvani; D Patrick Caldwell; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

9.  Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition.

Authors:  Catherine C Tenn; Shitij Kapur; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2005-04-26       Impact factor: 4.530

10.  Enhanced conditioned eyeblink response acquisition and proactive interference in anxiety vulnerable individuals.

Authors:  Jacqueline L Holloway; Payal Trivedi; Catherine E Myers; Richard J Servatius
Journal:  Front Behav Neurosci       Date:  2012-11-16       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.